Search

everythinglearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Combining metformin with amoxicillin/clavulanate lowers blood sugar in diabetic female rats.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Tamsulosin's sulfonamide group may contribute to floppy iris syndrome.

Finasteride overdose can cause acute pancreatitis.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Monitoring for adverse effects in clinical treatments is crucial.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Upadacitinib improved multiple immune-related conditions in one patient.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.